The U.S. Food and Drug Administration (FDA) has approved a new tool for the early detection of dementia. AIRAmed, a German healthcare technology company, has been granted FDA 510(k) clearance for AIRAscore, a medical image management and processing system. The advanced artificial intelligence (AI) platform is now on its way to being deployed throughout the U.S.